Literature DB >> 19598217

Molecular resonance vs. coblation tonsillectomy in children.

Riccardo D'Eredità1, Loredana Bozzola.   

Abstract

BACKGROUND: Quantum molecular resonance coagulation is an innovative technology that uses molecular resonance to cut and coagulate precisely, cleanly, and hemostatically at low tissue temperature levels. This technology offers a new possibility for tonsillectomy.
OBJECTIVES: To compare molecular resonance (MRT) with coblation (CAT) devices for pediatric tonsillectomy. STUDY
DESIGN: Prospective, two-group, randomized trial in a tertiary care pediatric institution. One hundred fifty-seven children for whom tonsillectomy was indicated were randomly assigned to receive MRT (n = 79) or CAT (n = 78). Main outcome measures included intraoperative time, blood loss, postoperative pain, and weight loss. Histopathologic examination was performed on all excised tonsils. Patients, parents, and pathologist were blinded to surgical modality.
RESULTS: Histopathologic evaluation revealed significantly reduced thermal injury with MRT than with CAT (43 microns vs. 126, respectively, P < .001), and was statistically associated with reduced muscular, blood vessel, and nerve fiber damage. No intraoperative blood loss was observed in patients following MRT. Statistically significant reduced pain scores were related to the MRT (P < .002). In addition, the MRT method showed a quick return to normal diet with even weight gain during the 10-day postoperative period. One child in the CAT group experienced delayed bleeding and required readmission.
CONCLUSIONS: Molecular resonance for pediatric tonsillectomy resulted in significantly reduced histopathologic thermal injury and lower pain scores compared with coblation. Further studies are advised to support these data.

Entities:  

Mesh:

Year:  2009        PMID: 19598217     DOI: 10.1002/lary.20210

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  Postoperative Bleeding and Associated Utilization following Tonsillectomy in Children.

Authors:  David O Francis; Christopher Fonnesbeck; Nila Sathe; Melissa McPheeters; Shanthi Krishnaswami; Sivakumar Chinnadurai
Journal:  Otolaryngol Head Neck Surg       Date:  2017-01-17       Impact factor: 3.497

Review 2.  Coblation versus other surgical techniques for tonsillectomy.

Authors:  Melissa Pynnonen; Jennifer V Brinkmeier; Marc C Thorne; Lee Yee Chong; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2017-08-22

3.  Comparison of two modern and conventional tonsillectomy techniques in terms of postoperative pain and collateral tissue damage.

Authors:  Mehmet Fatih Boğrul; Asude Ünal; Fatih Yılmaz; Mehmet Eser Sancaktar; Mustafa Bakırtaş
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-13       Impact factor: 2.503

4.  Safety Parameters of Quantum Molecular Resonance Devices During Thyroid Surgery: Porcine Model Using Continuous Neuromonitoring.

Authors:  Hsin-Yi Tseng; Tzu-Yen Huang; Yi-Chu Lin; Jia Joanna Wang; How-Yun Ko; Cheng-Hsun Chuang; I-Cheng Lu; Pi-Ying Chang; Gregory W Randolph; Gianlorenzo Dionigi; Ning-Chia Chang; Che-Wei Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-22       Impact factor: 6.055

Review 5.  Hemorrhage rate after coblation tonsillectomy: a meta-analysis of published trials.

Authors:  Ralph Mösges; Martin Hellmich; Silke Allekotte; Kerstin Albrecht; Myriam Böhm
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-04       Impact factor: 2.503

6.  In-vitro analysis of Quantum Molecular Resonance effects on human mesenchymal stromal cells.

Authors:  Sabrina Sella; Valentina Adami; Eliana Amati; Martina Bernardi; Katia Chieregato; Pamela Gatto; Martina Menarin; Alessandro Pozzato; Gianantonio Pozzato; Giuseppe Astori
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

7.  The comparison of efficacy and complications of coblation and radiofrequency thermocoagulation for V2/V3 idiopathic trigeminal neuralgia: a retrospective cohort study of 292 cases.

Authors:  Chenhui Wang; Zhi Dou; Mengwei Yan; Yuanzhang Tang; Rui Zhao; Yujie Han; Jiaxiang Ni
Journal:  BMC Anesthesiol       Date:  2021-01-07       Impact factor: 2.217

8.  Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomide.

Authors:  Daniela Catanzaro; Gloria Milani; Angela Bozza; Martina Bernardi; Katia Chieregato; Martina Menarin; Anna Merlo; Paola Celli; Romina Belli; Daniele Peroni; Alessandro Pozzato; Gianantonio Pozzato; Fabio Angelo Raneri; Lorenzo Volpin; Marco Ruggeri; Giuseppe Astori
Journal:  Br J Cancer       Date:  2022-06-17       Impact factor: 9.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.